Breast Cancer Clinical Trials

415 studies are recruiting for breast cancer in the United States right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

By city

Studies, page 15

  1. Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases

    This is a Phase I/II Study to determine the safety and efficacy of Sacituzumab Govitecan and Zimberelimab with stereotactic radiation (SRS) in participants with metastatic triple negative breast cancer with brain metastases, compared to treatment with Sacituzumab Govitecan alone.

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Moffitt Cancer Center, Tampa, Florida
    Run by
    H. Lee Moffitt Cancer Center and Research Institute
  2. Prospective Breast Cancer Biospecimen Collection

    Tissue will be procured during a standard of care procedure the patient will already be scheduled to undergo. A one time blood draw will be performed at this time and an optional rectal swab for biome analysis may occur. Follow Up will only consist of chart review to determine date of recurrence, m…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Sidney Kimmel Cancer Center at Thomas Jefferson University, Philadelphia, Pennsylvania
    Run by
    Thomas Jefferson University
  3. SAVE Trial: SAfe Opioid Use Video Education

    The study will assess the efficacy of a standardized postoperative patient-centered intervention designed to educate patients on the opioid epidemic, the judicious use of opioids, and the proper disposal of opioids. This trial is a single-institution, randomized controlled trial comparing total pos…

    Stage
    Not phased
    Ages
    18 and older
    Site
    University of Utah Huntsman Cancer Institute, Salt Lake City, Utah
    Run by
    University of Utah
  4. Women Informed to Screen Depending on Measures of Risk (Wisdom Study)

    Most physicians still use a one-size-fits-all approach to breast screening in which all women, regardless of their personal history, family history or genetics (except BRCA carriers) are recommended to have annual mammograms starting at age 40. Mammograms benefit women by detecting cancers early wh…

    Stage
    Not phased
    Ages
    30 to 74
    Site
    University of Alabama at Birmingham, Birmingham, Alabama
    Locations
    11 in total
    Run by
    University of California, San Francisco
  5. BREAST Choice Decision Tool R21 - AIM2

    Breast reconstruction is a critical component of breast cancer treatment because it restores quality of life and body image after mastectomy. However, Spanish-speaking Latina women are significantly less likely to undergo reconstruction (13.5% vs. 41% for non-Latina White or highly acculturated Lat…

    Stage
    Not phased
    Ages
    18 and older
    Site
    The University of North Carolina, Chapel Hill, North Carolina
    Run by
    UNC Lineberger Comprehensive Cancer Center
  6. Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

    The goal of this interventional study is to optimize the protocol of FES PET/CT in Estrogen Receptor positive Breast cancer patients with Brain metastases. Patients will undergo MRI of the brain and FDG PET/CT brain as part of standard of care for radiation treatment planning. An additional 18F-FES…

    Stage
    Phase 4
    Ages
    18 and older
    Site
    New York-Presbyterian/Weill Cornell Medical Center, New York, New York
    Run by
    Weill Medical College of Cornell University
  7. WashU DIEP Flap Video and Patient Understanding Improvement

    Patients will complete a survey before and after watching the WashU DIEP Flap Video at their pre-operative standard of care visit, and a third survey at their post-operative standard of care visit. These surveys will use questions from SILS, APAIS, PEMAT, and AIM/IAM to assess the patient's health …

    Stage
    Not phased
    Ages
    18 and older
    Site
    Washington University School of Medicine, St Louis, Missouri
    Run by
    Washington University School of Medicine
  8. ASHBY: Accelerated Super-Hypofractionated Breast Brachytherapy

    The purpose of this study is to compare any good and bad effects of giving radiation treatment for breast cancer in 3 treatments over about 2 days.

    Stage
    Phase 2
    Ages
    45 to 79
    Site
    Virginia Commonwealth University, Richmond, Virginia
    Run by
    Virginia Commonwealth University
  9. Resistance and Aerobic Exercise for Prevention in Women With Dense Breasts (REP-D)

    The goal of this study is to learn more about how exercise might lower the risk of developing breast cancer in women with dense breast tissue by studying changes that occur in breast tissue and blood as a result of participating in an exercise program. The names of the study groups in this study ar…

    Stage
    Not phased
    Ages
    18 to 59
    Site
    Dana Farber Cancer Institute, Boston, Massachusetts
    Locations
    2 in total
    Run by
    Dana-Farber Cancer Institute
  10. Enhancing Mammography Programs for Outreach, Wellness, Education, and Resources (EMPOWER) in Underserved Populations Study

    This study is investigating the feasibility of a digital tool called a chatbot for providing educational information about mammography through a tablet, computer, or phone. This study will recruit participants who recently had a mammogram with the University of Utah. Based on their mammography resu…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Huntsman Cancer Institute/ University of Utah, Salt Lake City, Utah
    Run by
    University of Utah
  11. Building on Trust: Navigating Preventive Lung, Breast, and Prostate Cancer Screenings at Community Resource Spots

    To evaluate a community-based outreach initiative for screening, diagnosis, and treatment of breast, lung, and prostate cancers in underserved adults using the Reach, Effectiveness, Adoption, Implementation, Maintenance (RE-AIM) implementation science framework.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Adventhealth, Orlando, Florida
    Run by
    AdventHealth
  12. RADIANT: Pre-op Radiation With Abemaciclib and Letrozole

    This phase 1b study investigates the safety and feasibility of combining pre-operative radiation therapy with Cyclin-Dependent Kinase 4 (CDK4/6) inhibitors in participants with hormone receptor positive/HER2 negative (HR+/HER2-) breast cancer. The study aims to assess the benefits of concurrent use…

    Stage
    Phase 1
    Ages
    60 and older
    Site
    RWJBarnabas Health Clara Maas Medical Center, Belleville, New Jersey
    Locations
    4 in total
    Run by
    Mridula George, MD
  13. Breast Re-irradiation After Second Ipsilateral Lumpectomy

    The purpose of this research study is to test the safety and possible harms of treating breast cancer with reirradiation, after breast surgery. The researchers want to find out what effects (good and bad) reirradiation has on people who have already received radiation before surgery.

    Stage
    Not phased
    Ages
    40 and older
    Site
    Lynn Cancer Institute at Baptist Health, Inc., Boca Raton, Florida
    Locations
    2 in total
    Run by
    Youssef Zeidan
  14. TMEM-MRI: A Pilot Feasibility Study of MRI for Imaging of TMEM in Patients With Operable Breast Cancer

    The aim of this study is to assess feasibility of a new imaging technology in the management of breast cancer - Tumor Microenvironment of Metastasis - Magnetic Resonance imaging (TMEM-MRI).

    Stage
    Not phased
    Ages
    18 and older
    Site
    Montefiore Medical Center, The Bronx, New York
    Run by
    Montefiore Medical Center
  15. Neratinib in Combination With Ruxolitinib in Patients With mTNBC

    The goal of this clinical trial is to assess the safety and efficacy of combined ruxolitinib and neratinib in patients with chemotherapy-pretreated metastatic triple negative breast cancer. This trial will evaluate one dosing schedule of neratinib in ruxolitinib in patients with metTNBC with locore…

    Stage
    EARLY_Phase 1
    Ages
    18 and older
    Site
    Baylor University Medical Center, Baylor Charles A Sammons Cancer Center, Dallas, Texas
    Run by
    Baylor Research Institute
  16. A Study of a Comprehensive Prevention Program to Reduce Lymphedema After Axillary Lymph Node Dissection in People With Breast Cancer

    The purpose of this study to test whether a comprehensive program may help the lymph fluid to drain out of the arm and prevent lymphedema in participants with breast cancer.

    Stage
    Phase 3
    Ages
    18 to 75
    Site
    Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge, New Jersey
    Locations
    7 in total
    Run by
    Memorial Sloan Kettering Cancer Center
  17. Post-mastectomy Recovery: Comparing Preoperative PECS-II Blocks With Intraoperative Pectoral Blocks

    The purpose this research is to compare two different standards of care for pain management and two different standards of care for local numbing medicine for breast cancer patients who will have a total mastectomy.

    Stage
    Phase 4
    Ages
    18 and older
    Site
    University of Cincinnati Medical Center, Cincinnati, Ohio
    Run by
    University of Cincinnati
  18. RAD 1802: Pilot Trial of Five Fraction Stereotactic Body Radiotherapy for Early Stage Breast Cancer Patients Eligible for Post-Operative Accelerated Partial Breast Irradiation (APBI)

    This study offers 5 fractions of radiation treatment through partial breast irradiation in patients with early stage breast cancer after having a lumpectomy.

    Stage
    Not phased
    Ages
    18 to 99
    Site
    University of Alabama at Birmingham (UAB) Hazelrig-Salter Radiation Oncology Center (HSROC), Birmingham, Alabama
    Run by
    University of Alabama at Birmingham
  19. Lifting More Than Weights: Resistance Exercise Program Across Socioeconomic Groups for Cancer-Related Fatigue Management

    The long-term goal of this project is to improve the implementation of tailored resistance exercise interventions for Appalachian breast cancer survivors. To achieve this goal, the primary objective is to enhance the understanding of how biological, psychological, and social factors interact to inf…

    Stage
    Not phased
    Ages
    18 and older
    Site
    West Virginia University, Morgantown, West Virginia
    Run by
    West Virginia University
  20. High Risk Breast Clinic: Protocol for Women at Increased Risk for Developing Breast Cancer

    The overall goal of this project is to develop an integrative system of breast cancer risk assessment based on epidemiologic and biologic risk variables, as well as to develop or refine risk biomarkers which may be useful in predicting and monitoring response to prevention interventions.

    Stage
    Not phased
    Ages
    30 to 65
    Site
    University of Kansas Medical Center, Kansas City, Kansas
    Run by
    Carol Fabian, MD
  21. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    International registry for cancer patients evaluating the feasibility and clinical utility of an Artificial Intelligence-based precision oncology clinical trial matching tool, powered by a virtual tumor boards (VTB) program, and its clinical impact on pts with advanced cancer to facilitate clinical…

    Stage
    Not phased
    Ages
    Any age
    Site
    Massive Bio SYNERGY-AI site, Birmingham, Alabama
    Locations
    68 in total
    Run by
    Massive Bio, Inc.
  22. Surviving Daily Life

    The primary goal of this project is to evaluate the feasibility of a 14-day mobile daily diary study among racially diverse breast cancer survivors. Further, the investigators will examine the validity and reliability of the daily stress and daily cognitive performance measures among breast cancer …

    Stage
    Not phased
    Ages
    40 and older
    Site
    Thomas Jefferson University, Philadelphia, Pennsylvania
    Run by
    Thomas Jefferson University
  23. Collecting Tissue Samples for Future Research From Women Undergoing Surgery for Breast Cancer

    RATIONALE: Collecting and storing samples of tumor tissue from patients with breast cancer to study in the laboratory may help doctors learn more about cancer. PURPOSE: This phase I study is collecting tissue samples for future research from women undergoing surgery for breast cancer.

    Stage
    Not phased
    Ages
    Any age
    Site
    Robert H. Lurie Comprehensive Cancer Center at Northwestern University, Chicago, Illinois
    Run by
    Northwestern University
  24. Strength After Breast Cancer

    The goal of this study is to explore whether a group exercise program called Strength After Breast Cancer can be delivered in an outpatient physical therapy clinic to improve physical function among women after treatment for breast cancer. The main questions this study aims to answer are: * Can the…

    Stage
    Not phased
    Ages
    18 and older
    Site
    MGH Institute of Health Professions, Boston, Massachusetts
    Run by
    MGH Institute of Health Professions
  25. UNC Pleural Fluid Registry

    Research with biospecimens such as blood, tissue, or body fluids can help researchers understand how the human body works. Researchers can make new tests to find diseases, understand how treatments work, or find new ways to treat a disease. The purpose of this study is to collect biospecimens for r…

    Stage
    Not phased
    Ages
    18 and older
    Site
    UNC Lingeberger Comprehensive Cancer Center, Chapel Hill, North Carolina
    Run by
    UNC Lineberger Comprehensive Cancer Center

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.